Developer Robert Filippini is appealing a ruling that granted the liquidators for Keystone Asset Management’s expanded freezing orders of up to $158 million in assets as well as two family trusts and four luxury cars.
In the first penalty to be handed down for breaches of the Privacy Act, pathology services provider Australian Clinical Labs has agreed to cop a $5.8 million fine over a 2022 data breach that compromised the personal information of 223,000 customers of its Medlab business.
Former ANZ trader Etienne Alexiou has admitted during cross-examination that lewd messages sent to other bankers through Bloomberg’s messaging platform were inappropriate and could cause offence.
ANZ can’t call its former group chief risk officer — now a strategic advisor for Clayton Utz — to give evidence as it defends a whistleblower case by former trader Etienne Alexiou.
Jayco must spell out its claim that it explained the specific features of its recreational vehicles to customers, as part of its defence to an ACCC case over alleged misleading statements, a judge has said.
Deutsche Bank has appointed receivers to five pubs owned by Public Hospitality Group ahead of a bankruptcy hearing against the group’s owner and former KPMG partner, Jon Adgemis.
Piper Alderman claims a judge erred in finding there was no evidence that an agreement between Maurice Blackburn and Phi Finney McDonald to cooperate in running an ad tech class action against Google was struck for an anti-competitive purpose.
An entity associated with the director of defunct Sydney builder Quasar Constructions has failed to hand over details about its assets to liquidators, prompting further orders with a warning from the court.
A judge has signed of on a settlement struck by the liquidator for failed financial services firm Babcock & Brown, which will resolve all remaining and future shareholder disputes, which have beleaguered the liquidator for 12 years.
Abbey Animal Health has managed only a “pyrrhic victory” in a patent case against rival Virbac over an antiparasitic drug, and must withdraw its Levamox Duo product from the market, a court has found.